BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

512 related articles for article (PubMed ID: 28360212)

  • 21. Focal changes in diffusivity on apparent diffusion coefficient MR imaging and amino acid uptake on PET do not colocalize in nonenhancing low-grade gliomas.
    Rahm V; Boxheimer L; Bruehlmeier M; Berberat J; Nitzsche EU; Remonda L; Roelcke U
    J Nucl Med; 2014 Apr; 55(4):546-50. PubMed ID: 24566001
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Volumetric histograms-based analysis of apparent diffusion coefficients and standard uptake values for the assessment of pediatric sarcoma at staging: preliminary results of a PET/MRI study.
    Orsatti G; Zucchetta P; Varotto A; Crimì F; Weber M; Cecchin D; Bisogno G; Spimpolo A; Giraudo C; Stramare R
    Radiol Med; 2021 Jun; 126(6):878-885. PubMed ID: 33683542
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Post-radiotherapy apparent diffusion coefficient (ADC) in children and young adults with high-grade gliomas and diffuse intrinsic pontine gliomas.
    Carceller F; Jerome NP; Fowkes LA; Khabra K; Mackinnon A; Bautista F; Marshall LV; Vaidya S; Mandeville H; Morgan V; Leach MO; Koh DM
    Pediatr Hematol Oncol; 2019 Mar; 36(2):103-112. PubMed ID: 30978130
    [No Abstract]   [Full Text] [Related]  

  • 24. MR Imaging Correlates for Molecular and Mutational Analyses in Children with Diffuse Intrinsic Pontine Glioma.
    Jaimes C; Vajapeyam S; Brown D; Kao PC; Ma C; Greenspan L; Gupta N; Goumnerova L; Bandopahayay P; Dubois F; Greenwald NF; Zack T; Shapira O; Beroukhim R; Ligon KL; Chi S; Kieran MW; Wright KD; Poussaint TY
    AJNR Am J Neuroradiol; 2020 May; 41(5):874-881. PubMed ID: 32381545
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ADC Histogram Analysis of Pediatric Low-Grade Glioma Treated with Selumetinib: A Report from the Pediatric Brain Tumor Consortium.
    Vajapeyam S; Brown D; Ziaei A; Wu S; Vezina G; Stern JS; Panigrahy A; Patay Z; Tamrazi B; Jones JY; Haque SS; Enterline DS; Cha S; Jones BV; Yeom KW; Onar-Thomas A; Dunkel IJ; Fouladi M; Fangusaro JR; Poussaint TY
    AJNR Am J Neuroradiol; 2022 Mar; 43(3):455-461. PubMed ID: 35210278
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Correlation between standardized uptake value and apparent diffusion coefficient of neoplastic lesions evaluated with whole-body simultaneous hybrid PET/MRI.
    Rakheja R; Chandarana H; DeMello L; Jackson K; Geppert C; Faul D; Glielmi C; Friedman KP
    AJR Am J Roentgenol; 2013 Nov; 201(5):1115-9. PubMed ID: 24147485
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relation between FDG uptake and apparent diffusion coefficients in glioma and malignant lymphoma.
    Matsushima N; Maeda M; Umino M; Suzawa N; Yamada T; Takeda K
    Ann Nucl Med; 2012 Apr; 26(3):262-71. PubMed ID: 22311413
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular Drug Imaging:
    Jansen MH; Veldhuijzen van Zanten SEM; van Vuurden DG; Huisman MC; Vugts DJ; Hoekstra OS; van Dongen GA; Kaspers GL
    J Nucl Med; 2017 May; 58(5):711-716. PubMed ID: 27765855
    [TBL] [Abstract][Full Text] [Related]  

  • 29. T2-weighted, apparent diffusion coefficient and
    Crimì F; Stramare R; Spolverato G; Aldegheri V; Barison A; D'Alimonte L; Bao QR; Spimpolo A; Albertoni L; Cecchin D; Campi C; Quaia E; Pucciarelli S; Zucchetta P
    Tech Coloproctol; 2021 May; 25(5):569-577. PubMed ID: 33792823
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Population-Based Gaussian Mixture Model Incorporating 18F-FDG PET and Diffusion-Weighted MRI Quantifies Tumor Tissue Classes.
    Divine MR; Katiyar P; Kohlhofer U; Quintanilla-Martinez L; Pichler BJ; Disselhorst JA
    J Nucl Med; 2016 Mar; 57(3):473-9. PubMed ID: 26659350
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Histogram Analysis of Apparent Diffusion Coefficients for Occult Tonsil Cancer in Patients with Cervical Nodal Metastasis from an Unknown Primary Site at Presentation.
    Choi YJ; Lee JH; Kim HO; Kim DY; Yoon RG; Cho SH; Koh MJ; Kim N; Kim SY; Baek JH
    Radiology; 2016 Jan; 278(1):146-55. PubMed ID: 26115452
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Progressing Toward a Cohesive Pediatric 18F-FDG PET/MR Protocol: Is Administration of Gadolinium Chelates Necessary?
    Klenk C; Gawande R; Tran VT; Leung JT; Chi K; Owen D; Luna-Fineman S; Sakamoto KM; McMillan A; Quon A; Daldrup-Link HE
    J Nucl Med; 2016 Jan; 57(1):70-7. PubMed ID: 26471690
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Radiogenomics of diffuse intrinsic pontine gliomas (DIPGs): correlation of histological and biological characteristics with multimodal MRI features.
    Calmon R; Dangouloff-Ros V; Varlet P; Deroulers C; Philippe C; Debily MA; Castel D; Beccaria K; Blauwblomme T; Grevent D; Levy R; Roux CJ; Purcell Y; Saitovitch A; Zilbovicius M; Dufour C; Puget S; Grill J; Boddaert N
    Eur Radiol; 2021 Dec; 31(12):8913-8924. PubMed ID: 34003354
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multimodal Magnetic Resonance Imaging of Treatment-Induced Changes to Diffuse Infiltrating Pontine Gliomas in Children and Correlation to Patient Progression-Free Survival.
    Calmon R; Puget S; Varlet P; Beccaria K; Blauwblomme T; Grevent D; Sainte-Rose C; Castel D; Dufour C; Dhermain F; Bolle S; Saitovitch A; Zilbovicius M; Brunelle F; Grill J; Boddaert N
    Int J Radiat Oncol Biol Phys; 2017 Oct; 99(2):476-485. PubMed ID: 28871999
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 11C-methionine-18F-FDG dual-PET-tracer-based target delineation of malignant glioma: evaluation of its geometrical and clinical features for planning radiation therapy.
    Hirata T; Kinoshita M; Tamari K; Seo Y; Suzuki O; Wakai N; Achiha T; Umehara T; Arita H; Kagawa N; Kanemura Y; Shimosegawa E; Hashimoto N; Hatazawa J; Kishima H; Teshima T; Ogawa K
    J Neurosurg; 2019 Sep; 131(3):676-686. PubMed ID: 30239314
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enhancing tumor apparent diffusion coefficient histogram skewness stratifies the postoperative survival in recurrent glioblastoma multiforme patients undergoing salvage surgery.
    Zolal A; Juratli TA; Linn J; Podlesek D; Sitoci Ficici KH; Kitzler HH; Schackert G; Sobottka SB; Rieger B; Krex D
    J Neurooncol; 2016 May; 127(3):551-7. PubMed ID: 26830088
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hybrid [¹⁸F]-FDG PET/MRI including non-Gaussian diffusion-weighted imaging (DWI): preliminary results in non-small cell lung cancer (NSCLC).
    Heusch P; Köhler J; Wittsack HJ; Heusner TA; Buchbender C; Poeppel TD; Nensa F; Wetter A; Gauler T; Hartung V; Lanzman RS
    Eur J Radiol; 2013 Nov; 82(11):2055-60. PubMed ID: 23830904
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multiparametric evaluation of low grade gliomas at follow-up: comparison between diffusion and perfusion MR with (18)F-FDOPA PET.
    Rossi Espagnet MC; Romano A; Mancuso V; Cicone F; Napolitano A; Scaringi C; Minniti G; Bozzao A
    Br J Radiol; 2016 Oct; 89(1066):20160476. PubMed ID: 27505026
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Radiomic Features Based on MRI Predict Progression-Free Survival in Pediatric Diffuse Midline Glioma/Diffuse Intrinsic Pontine Glioma.
    Wagner MW; Namdar K; Napoleone M; Hainc N; Amirabadi A; Fonseca A; Laughlin S; Shroff MM; Bouffet E; Hawkins C; Khalvati F; Bartels U; Ertl-Wagner BB
    Can Assoc Radiol J; 2023 Feb; 74(1):119-126. PubMed ID: 35768942
    [No Abstract]   [Full Text] [Related]  

  • 40. The role of apparent diffusion coefficient histogram metrics for differentiating pediatric medulloblastoma histological variants and molecular groups.
    Gonçalves FG; Tierradentro-Garcia LO; Kim JDU; Zandifar A; Ghosh A; Viaene AN; Khrichenko D; Andronikou S; Vossough A
    Pediatr Radiol; 2022 Dec; 52(13):2595-2609. PubMed ID: 35798974
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.